UB Paderborn / Katalog / Suche / in CDI

1 – 24 von 24

Sortiert nach

Two different first-line 5-fluorouracil regimens with or without oxaliplatin in patients with metastatic colorectal cancer

Annals of oncology, 2009-02, Vol.20 (2), p.244-250

2009

Link zum Volltext

Verfügbarkeit prüfen

BRCA1 and BRCA2 mutations as prognostic factors in bilateral breast cancer patients

Annals of oncology, 2004-09, Vol.15 (9), p.1373-1376

2004

Link zum Volltext

Verfügbarkeit prüfen

Vascular Endothelial Growth Factor Polymorphisms in Relation to Breast Cancer Development and Prognosis

Clinical cancer research, 2005-05, Vol.11 (10), p.3647-3653

2005

Link zum Volltext

Verfügbarkeit prüfen

Carpal tunnel syndrome and musculoskeletal symptoms in postmenopausal women with early breast cancer treated with exemestane or tamoxifen after 2–3 years of tamoxifen: a retrospective analysis of the Intergroup Exemestane Study

The lancet oncology, 2012-04, Vol.13 (4), p.420-432

2012

Link zum Volltext

Verfügbarkeit prüfen

Therapeutic effects of epoetin zeta in the treatment of chemotherapy-induced anaemia

Current medical research and opinion, 2009-07, Vol.25 (7), p.1689-1697

2009

Link zum Volltext

Verfügbarkeit prüfen

OPTIMAL CYTOREDUCTION AS THE PROGNOSTIC FACTOR IN OVARIAN CANCER PATIENTS

International journal of gynecological cancer, 2003-03, Vol.13 (Suppl 1), p.47-47

2003

Link zum Volltext

Verfügbarkeit prüfen

Sex hormone-binding globulin polymorphisms in familial and sporadic breast cancer

Carcinogenesis (New York), 2002-08, Vol.23 (8), p.1315-1320

2002

Link zum Volltext

Verfügbarkeit prüfen

High frequency of recurrent mutations in BRCA1 and BRCA2 genes in Polish families with breast and ovarian cancer

Human mutation, 2000-12, Vol.16 (6), p.482-490

2000

Link zum Volltext

Verfügbarkeit prüfen

Germline Mutations in BRCA1 and BRCA2 in Polish Families Predisposed to Breast and Ovary Cancers

Disease markers, 1999-01, Vol.15 (1-3), p.103-103

1999

Link zum Volltext

Verfügbarkeit prüfen

Polymorphisms and haplotype structures in genes for transforming growth factor beta1 and its receptors in familial and unselected breast cancers

International journal of cancer, 2004-10, Vol.112 (1), p.94-99

2004

Link zum Volltext

Verfügbarkeit prüfen

Germline mutations in the BRCA1 gene predisposing to breast and ovarian cancers in Upper Silesia population

Acta biochimica polonica, 2002-01, Vol.49 (2), p.351-356

2002

Link zum Volltext

Verfügbarkeit prüfen

Sequential combination of radio-chemotherapy (5-fluorouracil, cis-platinum and irradiation) in the management of locally advanced head and neck cancers

Neoplasma, 1996, Vol.43 (1), p.37

1996

Link zum Volltext

Verfügbarkeit prüfen

Navelbine (NVB) oral (o) with cisplatin (CDDP) as induction and concomitant to radiotherapy (RT): Final results of an international phase II trial in stage III non-small cell lung cancer (NSCLC)

Journal of clinical oncology, 2007-06, Vol.25 (18_suppl), p.7691-7691

2007

Link zum Volltext

Verfügbarkeit prüfen

BRCA1/2 mutations as prognostic factors in bilateral breast cancer (BC) patients

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.9647-9647

2004

Link zum Volltext

Verfügbarkeit prüfen

BRCA1/2 mutations as prognostic factors in bilateral breast cancer (BC) patients

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.9647-9647

2004

Link zum Volltext

Verfügbarkeit prüfen

Final results of a randomized phase III study evaluating the addition of oxaliplatin first line to 5-FU followed by irinotecan at progression in advanced colorectal cancer (LIFE study)

Journal of clinical oncology, 2005-06, Vol.23 (16_suppl), p.3517-3517

2005

Link zum Volltext

Verfügbarkeit prüfen

P-520 Navelbine oral with cisplatin as induction and concomitant to radiotherapy: A new option for the treatment of stage III non-small cell lung cancer (NSCLC)

Lung cancer (Amsterdam, Netherlands), 2005-07, Vol.49, p.S254-S254

2005

Link zum Volltext

Verfügbarkeit prüfen

170. Ocena tolerancji i skuteczności leczenia irinotekanem chorych na raka jelita grubego w stadium rozsiewu – doświadczenie własne

Reports of practical oncology and radiotherapy, 2003, Vol.8, p.S262-S263

2003

Link zum Volltext

Verfügbarkeit prüfen

177. Wstępna ocena skuteczności i toksyczności leczenia Capecytabiną w zaawansowanym raku jelita grubego

Reports of practical oncology and radiotherapy, 2003, Vol.8, p.S267-S267

2003

Link zum Volltext

Verfügbarkeit prüfen

488 Adjuvant radiotherapy in stage I ovarian cancer

European journal of cancer (1990), 1995-11, Vol.31, p.S104-S104

1995

Link zum Volltext

Verfügbarkeit prüfen

408 New sequence variants, recurrent BRCA1/BRCA2 mutations and new aberrations in BRCA1 promoter region in breast and ovarian cancer cases from upper silesia in Poland

European journal of cancer supplements, 2003-09, Vol.1 (5), p.S124-S125

2003

Link zum Volltext

Verfügbarkeit prüfen

409 Clinical prognosis of BRCA1-associated breast cancer: a cohort study from the upper silesia region in Poland

European journal of cancer supplements, 2003-09, Vol.1 (5), p.S125-S125

2003

Link zum Volltext

Verfügbarkeit prüfen

Clinical evaluation of Mitexan in the prevention of urinary tract complications during treatment with Holoxan

Nowotwory, 1981, Vol.30 (4), p.377

1981

Link zum Volltext

Verfügbarkeit prüfen

Preliminary evaluation of the effectiveness of holoxan in the treatment of malignant soft tissue and bone neoplasms

Nowotwory, 1981, Vol.31 (2), p.147

1981

Link zum Volltext

Verfügbarkeit prüfen

1 – 24 von 24

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(24)
Mit Volltextzugriff
(21)

Publikationsform

Artikel
(24)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(12)
Female
(10)
Life Sciences & Biomedicine
(10)
Science & Technology
(10)
Middle Aged
(9)
Adult
(8)
Aged
(8)
Breast Neoplasms - Genetics
(6)
Oncology
(6)
Aged, 80 And Over
(4)
Biological And Medical Sciences
(4)
Medical Sciences
(4)
Adolescent
(3)
Antineoplastic Agents
(3)
Antineoplastic Combined Chemotherapy Protocols - Adverse Effects
(3)
Case-Control Studies
(3)
Male
(3)
Medicin Och Hälsovetenskap
(3)
Pharmacology. Drug Treatments
(3)
Polymorphism, Genetic
(3)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Two different first-line 5-fluorouracil regimens with or without oxaliplatin in patients with metastatic colorectal cancer

BRCA1 and BRCA2 mutations as prognostic factors in bilateral breast cancer patients

Vascular Endothelial Growth Factor Polymorphisms in Relation to Breast Cancer Development and Prognosis

Carpal tunnel syndrome and musculoskeletal symptoms in postmenopausal women with early breast cancer treated with exemestane or tamoxifen after 2–3 years of tamoxifen: a retrospective analysis of the Intergroup Exemestane Study

Therapeutic effects of epoetin zeta in the treatment of chemotherapy-induced anaemia

OPTIMAL CYTOREDUCTION AS THE PROGNOSTIC FACTOR IN OVARIAN CANCER PATIENTS

Sex hormone-binding globulin polymorphisms in familial and sporadic breast cancer

High frequency of recurrent mutations in BRCA1 and BRCA2 genes in Polish families with breast and ovarian cancer

Germline Mutations in BRCA1 and BRCA2 in Polish Families Predisposed to Breast and Ovary Cancers

Polymorphisms and haplotype structures in genes for transforming growth factor beta1 and its receptors in familial and unselected breast cancers

Germline mutations in the BRCA1 gene predisposing to breast and ovarian cancers in Upper Silesia population

Sequential combination of radio-chemotherapy (5-fluorouracil, cis-platinum and irradiation) in the management of locally advanced head and neck cancers

Navelbine (NVB) oral (o) with cisplatin (CDDP) as induction and concomitant to radiotherapy (RT): Final results of an international phase II trial in stage III non-small cell lung cancer (NSCLC)

BRCA1/2 mutations as prognostic factors in bilateral breast cancer (BC) patients

BRCA1/2 mutations as prognostic factors in bilateral breast cancer (BC) patients

Final results of a randomized phase III study evaluating the addition of oxaliplatin first line to 5-FU followed by irinotecan at progression in advanced colorectal cancer (LIFE study)

P-520 Navelbine oral with cisplatin as induction and concomitant to radiotherapy: A new option for the treatment of stage III non-small cell lung cancer (NSCLC)

170. Ocena tolerancji i skuteczności leczenia irinotekanem chorych na raka jelita grubego w stadium rozsiewu – doświadczenie własne

177. Wstępna ocena skuteczności i toksyczności leczenia Capecytabiną w zaawansowanym raku jelita grubego

488 Adjuvant radiotherapy in stage I ovarian cancer

408 New sequence variants, recurrent BRCA1/BRCA2 mutations and new aberrations in BRCA1 promoter region in breast and ovarian cancer cases from upper silesia in Poland

409 Clinical prognosis of BRCA1-associated breast cancer: a cohort study from the upper silesia region in Poland

Clinical evaluation of Mitexan in the prevention of urinary tract complications during treatment with Holoxan

Preliminary evaluation of the effectiveness of holoxan in the treatment of malignant soft tissue and bone neoplasms

Suchergebnisse filtern